The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

BackgroundThis meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD).MethodsPubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies published...

Full description

Bibliographic Details
Main Authors: Jiaxuan Li, Xin Wu, Xin Tan, Shixin Wang, Ruisi Qu, Xiaofeng Wu, Zhouqing Chen, Zhong Wang, Gang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease
cognitive impairment
amyloid-β
monoclonal antibody
γ-secretase inhibitors
BACE-1 inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1257973/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2023.1257973/full

Similar Items